Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russia.
Savelyev University Surgical Clinic, Pirogov Russian National Research Medical University, Moscow, Russia.
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1049-1057. doi: 10.1016/j.jvsv.2020.02.012. Epub 2020 Mar 31.
The objective of this study was to assess the effect of various endovascular interventions on the clinical manifestations of the pelvic congestion syndrome (PCS) caused by May-Thurner syndrome (MTS).
The study included 12 female patients with PCS caused by MTS. Patients were examined by duplex ultrasound, computed tomography of the pelvic veins, and ovarian and pelvic venography. All 12 patients underwent endovascular stenting of the left common iliac vein (CIV), and 10 of them underwent subsequent endovascular embolization of the left gonadal vein. The indication for stenting was the presence of stenosis (>50%) of the CIV with clinical symptoms and signs of PCS. Self-expanding stents (Wallstent, 14-16 mm × 60-90 mm; Boston Scientific, Marlborough, Mass) were used. Patients with persistent symptoms of PCS after stenting underwent gonadal vein embolization with MReye metal coils (diameter, 10-15 mm; length, 10-20 cm; Cook Medical, Bloomington, Ind).
Technical success of stenting, namely, the restoration of normal patency of the left CIV, was achieved in 12 patients. In two patients, a stent was displaced toward the inferior vena cava, which required implantation of a second stent. In another patient, the stent was displaced into the inferior vena cava at 6 months after the intervention, which was not associated with any complication during the follow-up period. The mean venous pelvic pain severity score decreased from 7.7 ± 0.8 at baseline to 4.8 ± 0.3 after 1 month and stayed at this level during the 6-month follow-up period. Complete elimination of PCS symptoms at 6 months after stenting was achieved in 2 patients, and 10 patients underwent embolization of the left gonadal vein 6 months after stenting because of persistent pelvic pain.
Endovascular stenting of the left CIV is an effective technique for relieving symptoms of PCS due to MTS in only 16.6% of patients. Stenting of the left CIV in combination with embolization of gonadal veins results in elimination of the signs of PCS in 83.4% of patients. Probably only gonadal vein embolization can be used in the treatment of MTS-related PCS. To confirm this hypothesis, further comparative studies are warranted.
本研究旨在评估各种血管内介入治疗对由迈尔-特纳综合征(MTS)引起的盆腔淤血综合征(PCS)的临床症状的影响。
本研究纳入了 12 例由 MTS 引起的 PCS 女性患者。患者接受了双功能超声、盆腔静脉计算机断层扫描、卵巢和盆腔静脉造影检查。所有 12 例患者均接受了左侧髂总静脉(CIV)的血管内支架置入术,其中 10 例患者随后接受了左侧精索静脉的血管内栓塞术。支架置入的指征是存在 CIV 狭窄(>50%)伴有 PCS 的临床症状和体征。使用自膨式支架(Wallstent,14-16mm×60-90mm;波士顿科学,马萨诸塞州马尔伯勒)。支架置入后仍存在 PCS 症状的患者接受了 MReye 金属线圈(直径 10-15mm;长度 10-20cm;库克医疗,印第安纳州布卢明顿)的精索静脉栓塞术。
12 例患者的支架置入术均获得技术成功,即左侧 CIV 的通畅性得到恢复。在 2 例患者中,支架向下腔静脉移位,需要植入第二个支架。在另 1 例患者中,支架在介入治疗后 6 个月时移位至下腔静脉,但在随访期间未发生任何并发症。盆腔静脉疼痛严重程度评分从基线时的 7.7±0.8 降至 1 个月时的 4.8±0.3,并在 6 个月的随访期间保持在这一水平。支架置入后 6 个月,2 例患者完全消除了 PCS 症状,10 例患者由于持续性盆腔疼痛而在支架置入后 6 个月接受了左侧精索静脉栓塞术。
在 16.6%的患者中,血管内支架置入术治疗由 MTS 引起的 PCS 症状是有效的。左侧 CIV 支架置入术联合精索静脉栓塞术可使 83.4%的患者消除 PCS 体征。可能只有精索静脉栓塞术可用于治疗与 MTS 相关的 PCS。为了证实这一假设,需要进一步开展对比研究。